Real World Evidence (RWE) in Pharma Innovations
Pharmaceutical Patents Expiry: Generic Drug Development
Impact of Drug Patent Expiry on Prices: Recent Trends
Therapeutic Goods Administration TGA Regulation of Non-Prescription Medicine in Australia
EMA Measures Towards Efficient Approval Process for New Medicines in European Union (EU)
EMA's Clinical Trial Regulations (EUCTR) in European Union
NADFC (BPOM) Regulation of Pharmaceuticals in Indonesia
What Is a Marketing Authorization Holder (MAH)?
COFEPRIS Regulation of Nitrosamines in Pharmaceuticals in Mexico
The Use of Virtual Reality (VR) and Augmented Reality (AR) in Pharma Training and Education
Regulatory Challenges in Bringing Generic Drugs to the Market Post-Patent Expiry
Patent Expiry Alert: Blockbuster Drugs Expected to Lose Protection in the Next Five Years
US FDA Pharmacovigilance Requirements for Drugs in the USA
Artificial Intelligence (AI) and Machine Learning (ML) in Drug Discovery
Microbiome Based Therapies : Regulations and Market Outlook
US FDA Regulation of Nitrosamines in the USA
Innovative Drug Delivery Systems
Hong Kong: New Drugs, Generics, Biosimilar Regulations
Case Study: Regulatory Compliance and Registration of AI algorithm with MoHAP, UAE
Precision Medicine – Key Players and Pipeline
Insights
Global, Concurrent, Experience Based
Deep dive and engage in insightful discourse driven by concurrent global regulatory scenarios, industry trends and Artixio’s real-time experience across the product value chain. Whitepapers, research articles, landscape reports and case studies to help you stay ahead of the curve.
